Stocksigma LogoStocksigma Logo

Sun Pharma Subsidiaries Settle US Generic Drug Pricing Antitrust Litigation

Sun Pharmaceutical Industries Limited announced on 11th Sep'26 that its subsidiaries鈥擲un Pharmaceutical Industries, Inc., Taro Pharmaceutical Industries

Sun Pharma Subsidiaries Settle US Generic Drug Pricing Antitrust Litigation

Sun Pharmaceutical Industries Ltd 路 Others (Uncategorized) 路 12 Sept 2026, 1:27 am

Sun Pharma Subsidiaries Settle US Generic Drug Pricing Antitrust Litigation Sun Pharmaceutical Industries Limited announced on 11th Sep'26 that its subsidiaries鈥擲un Pharmaceutical Industries, Inc., Taro Pharmaceutical Industries Ltd., and Taro Pharmaceuticals U.S.A., Inc.鈥攈ave executed a settlement agreement with a plaintiff in the *In re Generic Pharmaceuticals Pricing Antitrust Litigation* in the Eastern District of Pennsylvania, U.S. The settlement involves a confidential payout in exchange for a full release of all asserted claims against the entities and related parties, without any admission of wrongdoing. Other terms remain confidential.

Original exchange filing (PDF)

More announcements from Sun Pharmaceutical Industries Ltd

All Sun Pharmaceutical Industries Ltd announcements